Recent FDA Guidance on Compounded GLP-1s: In October 2023, the FDA issued warnings about compounded GLP-1 medications, specifically cautioning patients to ensure theyre receiving semaglutide (the actual FDA-approved ingredient) rather than semaglutide salts, which have different properties
Osoby z chorobami przewlekymi, aktywn chorob nowotworow, podejrzeniem nowotworu, wieo zakoczonym leczeniem onkologicznym, kobiety w ciy oraz osoby stosujce leki powinny zachowa szczegln ostrono i skonsultowa si z lekarzem przed podjciem jakichkolwiek decyzji
Additionally, routine consultations with your healthcare provider can ensure that your medication regimen remains appropriate and effective over time
Symptoms include abdominal pain, bloating, nausea, vomiting, etc
Gu YY, Liu XS, Lan HY